Drug Database
Back to search

Poland· PL-100492981

Dagraduo

A sitagliptin und dapagliflozin product containing sitagliptinum + dapagliflozinum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 5 of our 19 countries.

ATC A10BD29

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDagraduoATCA10BD29REGISTER NO.PL-100492981PACKS LISTED10CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sitagliptinum + dapagliflozinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sitagliptin und dapagliflozin is registered in 5 of 19 countries.

Countries holding a registration under ATC A10BD29 (sitagliptin und dapagliflozin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search sitagliptin und dapagliflozin products by name

Sitagliptin und dapagliflozin · ATC A10BD29

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Sitagliptinum + Dapagliflozinum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
A10BD29
ATC class
Sitagliptin und Dapagliflozin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 10

  • gtin
    03838989780715
  • gtin
    03838989780609
  • gtin
    03838989780623
  • gtin
    03838989780647
  • gtin
    03838989780661
  • gtin
    03838989780685
  • gtin
    03838989780708
  • gtin
    03838989780616
  • gtin
    03838989780654
  • gtin
    03838989780692

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sitagliptin und dapagliflozin in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sitagliptin und dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Sitagliptin/Dapagliflozin Ratiopharm, Sitagliptin/Dapagliflozin Tad
  • Belgium · Dibaglep
  • Bulgaria · Даградуо, Далзиор S Комбо
  • Cyprus · Gludapsi, Sitagliptin/Dapagliflozin Tad
  • Czechia · Dagrafors Duo
  • Germany · Dagraduo, Dapasitazin
  • Estonia · Dagraduo, Sitagliptin/Dapagliflozin Teva
  • Finland · Dagraduo
  • Greece · Dagraduo, Dapsita
  • Croatia · Daglyfy, Dagraduo
  • Hungary · Dagrafors Duo
  • Lithuania · Axigalu
  • Luxembourg · Dibaglep
  • Latvia · Daplussi, Sitagliptin/Dapagliflozin Teva
  • Malta · Gludapsi
  • Portugal · Dagraduo
  • Romania · Dagraduo, Dibaglep
  • Sweden · Ermegisto, Sidaglya
  • Slovenia · Daplussi
  • Slovakia · Dagraduo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e2997b44-fbac-480a-9274-fe2d1af40d10
GET /v1/drugs/e2997b44-fbac-480a-9274-fe2d1af40d10?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "100 mg + 10 mg",
  "packaging": "03838989780609 ¦ Rp ¦ 163600\n28 tabl. w blistrze lub blistrze perforowanym\n03838989780623 ¦ Rp ¦ 163601\n30 tabl.\n03838989780647 ¦ Rp ¦ 163602\n56 tabl. w blistrze lub blistrze perforowanym\n03838989780661 ¦ Rp ¦ 163603\n60 tabl.\n03838989780685 ¦ Rp ¦ 163604\n84 tabl. w blistrze lub blistrze perforowanym\n03838989780708 ¦ Rp ¦ 163605\n90 tabl.\n03838989780616 ¦ Rp ¦ 163606\n28 tabl. w blistrze kalendarzowym\n03838989780654 ¦ Rp ¦ 163607\n56 tabl. w blistrze kalendarzowym\n03838989780692 ¦ Rp ¦ 163608\n84 tabl. w blistrze kalendarzowym\n03838989780715 ¦ Rp ¦ 163609\n98 tabl.",
  "substance": "Sitagliptinum 100 mg + Dapagliflozinum 10 mg",
  "common_name": "Sitagliptinum + Dapagliflozinum",
  "pl_product_id": "100492981",
  "pozwolenie_nr": "29270",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-09-01"
}
API referenceMCP serverPlans

See everything about sitagliptin und dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console